“…In recent years, mesoporous silica nanomaterials have attracted much attention as drug delivery carriers due to their unique advantages, such as high specific surface area and large pore volume, homogeneous controllable particle size, easily modified surface and good biocompatibility Zhang et al, 2010Zhang et al, , 2014Mellaerts et al, 2008). Moreover, mesoporous silicaassisted drug delivery systems have increasingly focused on stimuli-responsive CDDSs that can release encapsulated drugs from silica carriers at the expected site in response to various stimuli including pH, redox potential, temperature, photoirradiation, and biomacromolecule (Yang et al, 2012;Meng et al, 2010;Zhou et al, 2007;He et al, 2012;Bernardos et al, 2010). Many available functionalized mesoporous silica nanoparticles (MSNs) have been developed to regulate drug release by capping the outlets of mesopore or encapsulating drugs within the porous channels of MSNs.…”